Effectiveness and Safety of Anlotinib-Related Therapeutic Regimens in Patients with Previously Immune Checkpoint Inhibitors-Treated Advanced NSCLC: A Real-World Exploratory Study

Fang XS, Zhang TS, Li SJ, Zhao YL, Li JB, Xia H, Wang RT

Drug Design, Development and Therapy 2025, 19:7527-7540

Published Date: 29 August 2025